Altimmune, Inc. (ALT)
4.62
-0.04
(-0.86%)
USD |
NASDAQ |
Feb 11, 16:00
4.62
0.00 (0.00%)
After-Hours: 17:00
Altimmune Market Cap : 482.06M for Feb. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CorMedix, Inc. | 586.19M |
| Actinium Pharmaceuticals, Inc. | 35.10M |
| Aldeyra Therapeutics, Inc. | 321.27M |
| Viking Therapeutics, Inc. | 3.231B |
| Seres Therapeutics, Inc. | 123.00M |
Market Cap Related Metrics
| PS Ratio | 18347.41 |
| Price to Book Value | 2.597 |
| Price | 4.62 |
| Earnings Yield | -23.13% |